Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation
- 29 July 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (3) , 474-479
- https://doi.org/10.1016/s0006-291x(03)01392-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiogenic capacity of endothelial cells in islets of LangerhansThe FASEB Journal, 2003
- Recent Developments in Protein Microarray TechnologyAngewandte Chemie International Edition in English, 2003
- Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic miceDiabetologia, 2002
- Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosisThe FASEB Journal, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α, TGF-β, bFGF and Vimentin) in cultured and transplanted rat isletsDiabetologia, 2000
- Genes induced by growth arrest in a pancreatic β cell line: identification by analysis of cDNA arraysFEBS Letters, 1999
- Investigation of the epitopic structure of thymosin β10 by epitope mapping experimentsPeptides, 1999
- Vascular development and disorders: Molecular analysis and pathogenic insightsKidney International, 1998
- VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED IN DEVASCULARIZED RAT ISLETS OF LANGERHANS IN VITRO1Transplantation, 1997